Nutritional Growth Solutions Ltd. · ASX:NGS
Nutritional Growth Solutions — Shareholder Meeting (July 2024)
10 slides from Nutritional Growth Solutions's shareholder meeting presentation, Jul 1, 2024
Slide 1: 2024 Annual General Meeting: Chair's Address and Managing Director's Presentation
ASX ANNOUNCEMENT | 1 JULY 2024 Nutritional Growth Solutions Limited (ASX: NGS) 2024 Annual General Meeting Chair’s Address and Managing Director’s Presentation Nutritional Growth Solutions Limited (ASX:NGS) ("NGS" or "the Company") advises the following address and presentation are attached and will
Slide 2: About Nutritional Growth Solutions
ASX ANNOUNCEMENT | 1 JULY 2024 This announcement has been authorised for release by the NGS Board of Directors. For further information, please contact: Stephen Turner Managing Director and CEO steve@healthyheights.com For personal use only About Nutritional Growth Solutions Nutritional Growth Solut
Slide 3: CEO Business Update
ASX: NGS For personal use only CEO Business Update Steve Turner CEO
Slide 4: Healthy Heights Product Portfolio
HEALTHY HEIGHTS® PRODUCT PORTFOLIO For personal use only Healthy Heights® was developed by an expert team of pediatric endocrinologists and nutritionists, offering a comprehensive range of nutritional shakes and supplements, patented and clinically proven to support children’s growth development. Wi
Slide 5: Strategic Highlights
STRATEGIC HIGHLIGHTS NGS is a nutritional company headquartered in the United States. We develop, produce and sell clinically tested For personal use only nutritional supplements for children, underpinned by 20 years of medical research in pediatric nutrition. Strong Gross Profit Margin Walmart reta
Slide 6: FY23: Consistent Sales Performance
FY23: CONSISTENT SALES PERFORMANCE Continued focus on the U.S. market and building sales momentum in Walmart delivered consistent For personal use only steady growth in 2023. 2023 Quarterly Revenue Trend 2018 - 2023 REVENUE $1,600 1,561 US$3.1m $1,500 A$4.7m $1,400 $1,300 1,227 1,256 1,230 1,194 $1,
Slide 7: Key Milestones
KEY MILESTONES For personal use only Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 • New CEO • Strategic restructure • Distribution of Happy • Completion of • 87% sales increase • Walmart confirms appointment to to reduce costs and Tummies® to 795 clinical trial for on iHerb ranging of Kids Protei
Slide 8: 1H FY24: YTD Revenue Constrained by Undercapitalisation
1H FY24: YTD REVENUE CONSTRAINED BY UNDERCAPITALISATION For personal use only 1H 2024 sales growth was constrained by supply chain disruptions and the prioritisation of cash preservation. • Optimised Profitability: Although revenues were constrained in 1H 2024 due to limited working capital, relativ
Slide 9: 2H FY24: Positive Outlook
2H FY24: POSITIVE OUTLOOK For personal use only With the Company recapitalised, NGS is confident in returning to strong sales performance and profitable growth. • Return to Growth: With access to adequate working capital to build inventory cover and invest in proven effective marketing activities, t
Slide 10: Strategic Priorities: Key Growth Engines
STRATEGIC PRIORITIES: KEY GROWTH ENGINES The Company remains laser-focused on the North American opportunity, leveraging our experienced American For personal use only team and established distribution network to penetrate the lucrative U.S. retail market. LINE EXTENSION COOKBOOKS INCREASE EXPAND U.
Nutritional Growth Solutions — Shareholder Meeting (July 2024) on 6ix